Earlier this year, the U.S. Department of Health and Human Services ("HHS") announced the expiration of the COVID-19 public health emergency declarations.
On January 31, 2020, in response to the COVID-19 pandemic, the Secretary of Health and Human Services (HHS) issued a declaration of a public health emergency (PHE) under Section.
This week, the U.S. Food & Drug Administration (FDA) issued two much anticipated guidances, each outlining how COVID-19 devices will be treated after the expiration of the COVID-19 public health emergency (PHE).
On March 1, 2023, the Drug Enforcement Agency (DEA) officially published proposed rules for prescribing controlled substances via telemedicine after the COVID-19 Public Health Emergency expires.
As more businesses transition from allowing remote work to mandating a return to the office, apart from the general employee backlash, one of the biggest HR compliance issues companies face.